Segall Bryant & Hamill’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $5.83M | Sell |
|
|||||
|
2024
Q4 | $8.53M | Sell |
|
|||||
|
2024
Q3 | $37.9M | Buy |
|
|||||
|
2024
Q2 | $32.1M | Sell |
|
|||||
|
2024
Q1 | $31.8M | Sell |
|
|||||
|
2023
Q4 | $25.8M | Sell |
|
|||||
|
2023
Q3 | $55.8M | Sell |
|
|||||
|
2023
Q2 | $53.7M | Buy |
|
|||||
|
2023
Q1 | $51.9M | Buy |
|
|||||
|
2022
Q4 | $40.8M | Buy |
|
|||||
|
2022
Q3 | $25.7M | Buy |
|
|||||
|
2022
Q2 | $315K | Hold |
|
|||||
|
2022
Q1 | $314K | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $278K | Buy |
|
|||||
|
2021
Q2 | $220K | Buy |
|